Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy.
暂无分享,去创建一个
F. Guillemin | A. Saraux | J. Berthelot | B. Combe | O. Meyer | B. Fautrel | D. Wendling | A. Cantagrel | R. Flipo | X. le Loët | J. Maillefert | F. Lioté | M. de Bandt